Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

コートリモクサゾール毒性

F Shann

    Lancet (London, England)
    |December 22, 1984
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Corrigendum to "Critical Care Outcome Prediction Equation (COPE) model, version 7" [Crit Care Resusc 27 (4) (2025) 100131].

    Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2026
    Same author

    ANZROD, COPE 4 and PIM 3: caveat emptor.

    Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2014
    Same author

    Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2013
    Same author

    Validation of the hospital outcome prediction equation (HOPE) model for monitoring clinical performance.

    Internal medicine journal·2009
    Same author

    WITHDRAWN: Antibiotics for preventing pneumonia in children with measles.

    The Cochrane database of systematic reviews·2007
    Same author

    Outcome-based clinical indicators for intensive care medicine.

    Anaesthesia and intensive care·2005
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る